Bcl-2 overexpression attenuates dopamine
โ
Jean Lud Cadet; Beverly Harrington; Sonia Ordonez
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 163 KB
๐ 2 views
Parkinson's disease is a neurodegenerative disease that is consequent to the loss of brain dopamine (DA) cells. These abnormalities are thought, in part, to be a manifestation of increased free radical production during the metabolism of catecholamines. The antiapoptic agent, bcl-2, has been shown t